Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 5/20 | 0.43 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27449909 | 1.00 | DNM1 (0.43) | DNM1PLA2G1BPLA2G2AGGPS1OPRM1 | |
| SCHEMBL27449951 | 1.00 | DNM1 (0.43) | DNM1PLA2G1BPLA2G2AGGPS1OPRM1 | |
| SCHEMBL27449911 | 1.00 | DNM1 (0.43) | DNM1PLA2G1BPLA2G2AGGPS1OPRM1 | |
| SCHEMBL14640350 | 0.82 | SPHK1 (0.47) | DNM1PLA2G1BPLA2G2AOPRM1SPHK1 | |
| SCHEMBL5539887 | 0.81 | DNM1 (0.48) | DNM1PLA2G1BPLA2G2AOPRM1SPHK1 | |
| SCHEMBL10674908 | 0.81 | DNM1 (0.48) | DNM1PLA2G1BPLA2G2AOPRM1SPHK1 | |
| SCHEMBL28601890 | 0.81 | DNM1 (0.48) | DNM1PLA2G1BPLA2G2AOPRM1SPHK1 | |
| SCHEMBL21122273 | 0.81 | DNM1 (0.42) | DNM1PLA2G1BPLA2G2AOPRM1SPHK1 | |
| SCHEMBL21942495 | 0.81 | DNM1 (0.42) | DNM1PLA2G1BPLA2G2AOPRM1SPHK1 | |
| SCHEMBL5544717 | 0.81 | DNM1 (0.48) | DNM1PLA2G1BPLA2G2AOPRM1SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | OHIO STATE INNOVATION FOUNDATION (US) | 2024-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | MTREX, HAVCR2, TSG101 | DNM1 1194/4885PLA2G1B 746/4885PLA2G2A 386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.